Abstract
September 2021 saw a number of companies with a therapeutic delivery focus announce positive funding news including Windgap, Nanoform and Locate Bio. This month also saw approvals for a number of enhanced delivery therapeutics including Janssen’s, Invega Hafyera and RenovoRx’s RenovoCath. Collaborations announced this month included Impel NeuroPharma with Phil Inc. and Vect-Horus and MDimune.
| Original language | English |
|---|---|
| Pages (from-to) | 5-11 |
| Number of pages | 7 |
| Journal | Therapeutic Delivery |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2022 |